Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.

Malabarba MG, Rui H, Deutsch HH, Chung J, Kalthoff FS, Farrar WL, Kirken RA.

Biochem J. 1996 Nov 1;319 ( Pt 3):865-72.

2.

STAT6: its role in interleukin 4-mediated biological functions.

Takeda K, Kishimoto T, Akira S.

J Mol Med (Berl). 1997 May;75(5):317-26. Review.

PMID:
9181473
3.

Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system.

Murata T, Taguchi J, Puri RK, Mohri H.

Int J Hematol. 1999 Jan;69(1):13-20. Review.

PMID:
10641437
4.

Signalling by cytokines interacting with the interleukin-2 receptor gamma chain.

Demoulin JB, Renauld JC.

Cytokines Cell Mol Ther. 1998 Dec;4(4):243-56. Review.

PMID:
10068058
5.

Coupling of the IL2 receptor complex with non-receptor protein tyrosine kinases.

Miyazaki T, Taniguchi T.

Cancer Surv. 1996;27:25-40. Review.

PMID:
8909793
6.

Interleukin 4: signalling mechanisms and control of T cell differentiation.

Paul WE.

Ciba Found Symp. 1997;204:208-16; discussion 216-9. Review.

PMID:
9107423
7.

Signal transduction through the IL-4 and insulin receptor families.

Wang LM, Keegan A, Frankel M, Paul WE, Pierce JH.

Stem Cells. 1995 Jul;13(4):360-8. Review.

PMID:
7549895
8.

Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Hanke JH, Pollok BA, Changelian PS.

Inflamm Res. 1995 Sep;44(9):357-71. Review.

PMID:
8846193
9.

Targeting IL4/IL4R for the treatment of epithelial cancer metastasis.

Bankaitis KV, Fingleton B.

Clin Exp Metastasis. 2015 Dec;32(8):847-56. doi: 10.1007/s10585-015-9747-9. Epub 2015 Sep 18. Review.

PMID:
26385103
10.

JAK3: a two-faced player in hematological disorders.

Cornejo MG, Boggon TJ, Mercher T.

Int J Biochem Cell Biol. 2009 Dec;41(12):2376-9. doi: 10.1016/j.biocel.2009.09.004. Epub 2009 Sep 9. Review.

11.

Is JAK3 a new drug target for immunomodulation-based therapies?

Papageorgiou AC, Wikman LE.

Trends Pharmacol Sci. 2004 Nov;25(11):558-62. Review.

PMID:
15491777
12.

Disruption of cytokine signaling in lymphoid development: unique contributions of the common cytokine gamma chain and the Jak3 kinase.

Eynon EE, Kuida K, Flavell RA.

J Interferon Cytokine Res. 1996 Sep;16(9):677-84. Review. No abstract available.

PMID:
8887051
13.

Interleukin-2 receptor signaling in regulatory T cell development and homeostasis.

Burchill MA, Yang J, Vang KB, Farrar MA.

Immunol Lett. 2007 Nov 30;114(1):1-8. Epub 2007 Sep 14. Review.

Items per page

Supplemental Content

Write to the Help Desk